Science News : ATVB 2013 : Wednesday

Updated:May 1,2013

web_masthead ATVB 13 Science News

Wednesday, May 1, 2013

Featured Videos



Featured Presentations

Dr. Harley Tse, Head photo, ATVB13
Harley Y. Tse
Wayne State Univ., Detroit, MI
 
Session: I C-Molecular and Cellular Biology of the Vessel Wall
T Cell Functions in a Novel Antigen-specific Experimentally-induced Model of Atherosclerosis
 
 


Slide photo, Dr. Marlene Grenon, ATVB13
Marlene Grenon
UCSF, San Francisco, CA
Session: I D-Contemporary Management of Peripheral Arterial Disease
The Association Between Erythrocyte n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Content and Inflammation in Male Patients With Peripheral Artery Disease (PAD)
 


Slide photo, Dr. Heather Gornik, ATVB 13
Dr. Heather Gornik, FAHA
Cleveland Clinic, Cleveland, OH
Session: D-Contemporary Management of Peripheral Arterial Disease
Comprehensive Care of the PAD Patient: Incorporating the Latest Evidence and Practice Guidelines into Clinical Vascular Practice
 


Slide photo, Anne Eichmann, ATVB 13
Anne Eichmann, PhD, MSc
Yale Univ. School of Medicine, New Haven, CT
II-Genetic and Molecular Determinants of Angiogenesis and Lymphangiogenesis
Guiding Development of Blood and Lymphatic Vessels
 


Dr. Lars Maegdefessel, Head photo, ATVB13
Lars Maegdefessel

Karolinka Inst., Stockholm, Sweden
 
Session: Aortic and Carotid Artery Disease
Array-based Profiling Reveals Biomarker and Therapeutic Potential for Different microRNAs in Patients with Symptomatic Carotid Stenosis
 


Related Statistics:
  • PAD affects about 8.5 million Americans 40 years and older and is associated with significant morbidity and mortality. PAD prevalence is higher in older individuals and appears to dis¬proportionately affect African Americans.
  • In 2010, there were 146,000 hospitalizations and about 13,850 deaths due to PAD.
  • In the general population, only about 10% of people with PAD have the classic symptom of intermittent claudication.
  • Among patients with established PAD, higher physical activity levels during daily life are associated with better overall survival rate, a lower risk of death because of CVD, and slower rates of functional decline.
  • Learn more in Heart Disease & Stroke Statistics: 2013 Update

Professional Online Network

Connect with over 30,000 heart and stroke professionals.